Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: Kimberly Lee who wrote (21831)	11/1/1999 6:56:00 PM
From: Dustin	Respond to of 108040

Kimberly, how do you get INCA info? I have tried to find a way to get access to the INCA book, but can not even get Instinet to reply to my emails. I have heard from a trader on the Pac Exchange options floor that the individual investor can get access to the book for a price. Thanks, Dustin

To: Kimberly Lee who wrote (21831)	11/1/1999 6:57:00 PM
From: Mopack	Read Replies (1) \| Respond to of 108040

Couldn't agree more with jam2000. Have only been lurking around here for a couple of days and what a difference it's made!! Thanks Kim and too many others to try and name individually. Continued success to all of you! Thanks again, Mopack

To: Kimberly Lee who wrote (21831)	11/1/1999 7:02:00 PM
From: stan s.	Respond to of 108040

Marketwatch story on how GUMM's hitting the message boards. cbs.marketwatch.com All Aboard On the message boards: Sayonara sniffles, GUMM to the rescue Also: Wit Capital buzz By Shawn Langlois, CBS MarketWatch Last Update: 5:44 PM ET Nov 1, 1999 NewsWatch Join the discussion Will the common cold go way of the dinosaur? That might be a stretch, but GumTech shareholders are betting that the company's homeopathic cold remedy, Zicam, might be the virus-fighting tool of the future. The fire was fueled on Monday as bullish studies began to surface regarding the drug's efficacy. The Street embraced the news, catapulting GumTech (GUMM: news, msgs) through it's all-time high, and, of course, the message boards were abuzz. On Silicon Investor, posters, like CCCrawford, reveled in the moment: "This thing is for real. Maybe I'll try some of that Zicam on my next cold. I hear it works better when you're long." HowardE, MD: "My guess is that this first article is one step to putting down colds and getting rid of those snotty hankies forever. Bring on the second study!" And StreetWalker looked to a boundless future: "Investors are lucky to be alive at this time so they can invest in GUMM and pass their shares down through the generations. ZICAM is going international, and GUMM will be over $100+ in the future. ELIMINATE the cold in 1.5 days? That is news for the history of mankind!" As usual, the loudest cheers could be found on Yahoo. Cedarman was all atwitter as the cliches flew: "Bang the drums, launch the rockets and get out of the way. There is a train leaving the station. Can anyone say, 'WHOO WHOO'? Isn't it customary to tar and feather the shorts before running them out of town?" DadDollar kept with the theme: "Wow! This is it. Elvis has left the building. He is on the GUMM train heading due north. What a great way to start the week and month and we all know there is a lot more good news coming very soon." Sounds like Cold1Night oughtta keep the radio off during his commute: "Almost crashed my car while driving in this morning. News radio announced that USA Today was touting a revolutionary new cold remedy called Zicam. They named the product, Zicam, 5 times and said it reduced colds to 1.5 days. I almost drove off the road I was screaming so loud!! A plug from the King of All Media? Apparently so, according to DaHalls: "I just heard from a co-worker that Robin from the Howard Stern show did a report on Zicam this morning. Apparently she announced it as the new miracle cure for the common cold." Almost everybody indulged in gratuitous back-patting, but there were a few rare bears, like MrRetiredYung who maintained an "anti" stance: "Gum Tech faces significant competition from a large number of major drug companies involved in selling cold and flu products that will compete directly with Zicam. Most of these competitors have greater name recognition, more established brands, wider distribution capabilities and greater financial and marketing resources than Gum Tech." The bulls weren't about to let MrRetiredYung rain on their parade. The stock closed up 2 5/8 to 17 -- just off the highs of the day, but nothing to sneeze at! Wit woos SoundView Another group of ecstatic message board dwellers could be found on the Wit Capital boards. After a snappy market debut, shares of Wit Capital (WITC: news, msgs) took a pronounced turn for the worse. However, happy days are here again for shareholders as news of a major purchase hit the wire. Ringing endorsements for the deal crowded Raging Bull's boards where BO'Reilly gave the fresh addition a hearty thumbs-up: "SoundView management are truly, professional players." As did Memfields: "More capability to provide more shares to individual investors. More clout in the technology sector. Good news for shareholders! Get ready for more buyers to come in and the stock to finally move up toward 30." And this is only the beginning, according to WonderWorm: "More institutions coming on board. Once WITC beats estimates for the third straight quarter, it will be on! The institutional floodgates will be opened. Wit Capital Europe, Wit Capital Japan, Wit Capital USA -- year 2000 will be the year the Dynasty begins!" Mor4Mony let his approval be known on Yahoo: "COOL! Hold on to your WITC shares. Wit Capital will get bought out or GROW LIKE A WEED. They are in Asia now, and they will expand operations. Deal with CMGI brought in a huge number of accounts and they IPO many deals. I have an acct at witc and I am very happy there!" Speak for yourself, posted JPKelley -- not everyone was bullish on the company: "After trying to get quality IPOs for eight months and receiving NONE -- I GIVE UP. The only allocation I have received thus far was for WITC. In order to get an allocation at WITC, you need to sit in front of your computer waiting for e-mails. Not to mention the trade execution sucks. And customer service is non-existent. I will be transferring my funds to another online broker this week. To the rest of you best of luck trying to 'strike it rich' with the help of Wit Capital. I personally found the whole experience rather frustrating." Ouch, a trip to the boards would hardly be complete without a proper dose of cynicism. But, despite a moderate amount of bashing, the stock continued to retrace lost ground, up 27 percent to 22 3/8, and, in doing so, gave beleaguered shareholders reason to hold tight. See related story. Shawn Langlois is community editor for CBS MarketWatch.

To: Kimberly Lee who wrote (21831)	11/2/1999 12:47:00 AM
From: Zeddie88	Respond to of 108040

Kimberly, Thanks for a great thread with wonderful people who so generously share their DD so that we may all benefit. I am doing some DD on GUMM and would like contribute by pointing out that GUMM can be more than just a short-term play for the sniffly season. Yes, GUMM has Zicam for the sniffies and other cold miseries, but GUMM also has the rather obvious chewing gum customized to serve a multitude of purposes such as weight loss and nicotine addiction without the harmful affects of tobacco. In fact, I just read that the nicotine market is HUGE and that GUMM rebuffed SmithKlineBeecham's advances for their nicotine gum (I hope that my favorite DD expert 2Mar$ can find the link to prove this point as the hour is late and I read it but can't find it again - sorry but this happens to Mommy traders who are constantly interupted by crying babies). I did find this link very useful as a place to begin some serious DD on GUMM: messages.yahoo.com. Sue:)